0001628280-24-011760.txt : 20240318 0001628280-24-011760.hdr.sgml : 20240318 20240318201734 ACCESSION NUMBER: 0001628280-24-011760 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240314 FILED AS OF DATE: 20240318 DATE AS OF CHANGE: 20240318 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Matushak Jay CENTRAL INDEX KEY: 0001977975 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40537 FILM NUMBER: 24760759 MAIL ADDRESS: STREET 1: C/O BRIGHT HEALTH GROUP, INC. STREET 2: 8000 NORMAN CENTER DRIVE, SUITE 900 CITY: MINNEAPOLIS STATE: MN ZIP: 55437 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: NeueHealth, Inc. CENTRAL INDEX KEY: 0001671284 STANDARD INDUSTRIAL CLASSIFICATION: HOSPITAL & MEDICAL SERVICE PLANS [6324] ORGANIZATION NAME: 02 Finance IRS NUMBER: 474991296 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 9250 NW 36TH STREET STREET 2: SUITE 420 CITY: DORAL STATE: FL ZIP: 33178 BUSINESS PHONE: 612-238-1321 MAIL ADDRESS: STREET 1: 9250 NW 36TH STREET STREET 2: SUITE 420 CITY: DORAL STATE: FL ZIP: 33178 FORMER COMPANY: FORMER CONFORMED NAME: Bright Health Group Inc. DATE OF NAME CHANGE: 20210309 FORMER COMPANY: FORMER CONFORMED NAME: Bright Health Inc. DATE OF NAME CHANGE: 20160404 4 1 wk-form4_1710807446.xml FORM 4 X0508 4 2024-03-14 0 0001671284 NeueHealth, Inc. NEUE 0001977975 Matushak Jay C/O NEUEHEALTH, INC. 8000 NORMAN CENTER DRIVE, SUITE 900 MINNEAPOLIS MN 55437 0 1 0 0 Chief Financial Officer 0 Common Stock 2024-03-14 4 S 0 173 7.06 D 9974 D Common Stock 2024-03-15 4 S 0 248 7.10 D 9726 D These shares were sold by the reporting person to cover tax withholding obligations upon the vesting of restricted stock units and were not discretionary transactions by the reporting person. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.76 and $7.45 per share. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.98 and $7.40 per share. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. /s/ Eric Halverson for Jay Matushak, Attorney-in-Fact 2024-03-18